These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30335070)

  • 1. [Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study)].
    Fedin AI; Belskaya GN; Kurushina OV; Kovalchuk VV; Starych EV; Chichanovskaya LV; Baranova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):35-42. PubMed ID: 30335070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of cortexin in acute and recovery periodes of hemispheric ischemic stroke].
    Belova LA; Mashin VV; Abramova VV; Proshin AN; Ovsjannikova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):38-42. PubMed ID: 27845314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of cortexin and memantinol (memantine) in the treatment of cognitive impairment in patients with chronic cerebral ischemia].
    Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):30-36. PubMed ID: 29460902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An open clinical trial of cortexin in treatment of brain ischemia].
    Mashin VV; Belova LA; Chaplanova OI; Khusnullina AF; Manasian AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):49-52. PubMed ID: 25403301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cognitive impairment in patients poluchennym ischemic stroke in the acute and early recovery periods in the process of neuroprotection low-dose drug cortexin].
    Belova LA; Mashin VV; Abramova VV; Proshin AN; Ovsjannikova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8 Pt 2):40-43. PubMed ID: 27905386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of Korteksin in acute period of hemispheric ischemic stroke].
    Belova LA; Mashin VV; Abramova VV; Slastyon EY; Belov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(7):30-34. PubMed ID: 30132453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency].
    Kurkin DV; Morkovin EI; Kalatanova AV; Bakulin DA; Verholyak DV; Kovalev NS; Dubrovina MA; Tyurenkov IN; Petrov VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7):84-89. PubMed ID: 34460162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy and pharmacoeconomic characteristics of the neuroprotection with low doses of cortexin in the treatment of acute ischemic stroke].
    Aliferova VM; Dadasheva MN; Doronin BM; Kovalenko AV; Lokshtanova TM; Martynov MIu; Meshkova KS; Salimov KA; Stakhovskaia LV; Chefranova ZhIu; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):41-6. PubMed ID: 24874316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX].
    Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):84-90. PubMed ID: 35175707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the efficacy and safety of application of the drug cortexin in the complex rehabilitation of verticalization in patients with ischemic stroke in the acute period].
    Mashin VV; Belova LA; Aizatullin IF; Pavlova VA; Slasten EV; Abramova VV; Belov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):62-67. PubMed ID: 31626220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy of neuropeptides in cerebrovascular pathology].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):88-93. PubMed ID: 28635743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A multicenter observation study of the efficacy of cortexin and recognan (citicoline) in the treatment of cognitive impairments in chronic cerebrovascular pathology].
    Belova LA; Mashin VV; Dudikov EM; Belov DV; Krupennikov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2):35-38. PubMed ID: 30874524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on memory impairment, cerebral circulation and morphological changes in the hippocampus of rats with chronic brain ischemia].
    Tyurenkov IN; Kurkin DV; Kalatanova AV; Dorotenko AR; Bakulin DA; Morkovin EI; Verholyak DV; Gorbunova YV; Atapina NV; Smirnov AV; Schmidt MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):83-89. PubMed ID: 32929929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of cortexin in the early rehabilitation period of ischemic stroke of moderate severity].
    Nurguzhaev ES; Mitrokhin DA; Izbasarova ASh; Nurguzhaev AE; Raimkulov BN; Abdil'manova BR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):66-9. PubMed ID: 19672239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats.
    Kurkin DV; Bakulin DA; Morkovin EI; Kalatanova AV; Makarenko IE; Dorotenko AR; Kovalev NS; Dubrovina MA; Verkholyak DV; Abrosimova EE; Smirnov AV; Shmidt MV; Tyurenkov IN
    PLoS One; 2021; 16(7):e0254493. PubMed ID: 34260655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the efficacy of Cellex and Cortexin in patients in the early recovery period of ischemic stroke].
    Khabirov FA; Khaibullin TI; Granatov EV; Akhmetova GI; Akhmetzyanov NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):11-15. PubMed ID: 33449527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of cortexin in the complex treatment of patients with chronic alcohol encephalopathy and polyneuropathy].
    Solov'ev AG; Elistratova TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):48-51. PubMed ID: 20517210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children].
    Zykov VP; Serebrennikova EB; Panchenko TN; Sycheva YB; Presnyakova SN; Mazur EL; Salova MN; Golubeva ES; Khromova SK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(3):27-31. PubMed ID: 29652302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EFFECT OF CORTEXIN ON THE QUALITY OF LIFE IN THE EARLY REHABILITATIVE PERIOD AFTER HEMISPHERIC ISCHEMIC STROKE].
    Belova LA; Mashin VV; Abramova VV; Proshin AN; Ovsyannikova AN
    Klin Med (Mosk); 2016; 94(2):138-43. PubMed ID: 27459764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.
    Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS
    Neurosci Behav Physiol; 2022; 52(6):836-841. PubMed ID: 36311877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.